What Are IgA Levels and How to Increase If Depleted?
There is no direct way to increase IgA levels—IgA deficiency cannot be "treated" or reversed with medications or supplements, and IgA replacement therapy does not exist. Management focuses entirely on treating complications when they occur, not on raising IgA levels themselves 1.
Understanding IgA Levels
IgA deficiency is defined as serum IgA <7 mg/dL in individuals over 4 years of age, with normal IgG and IgM levels 1. This is the most common primary immunodeficiency, affecting approximately 1 in 300-700 white individuals in the United States 1.
Key Diagnostic Points:
- Age matters critically: Do not diagnose IgA deficiency before age 4, and recent evidence suggests waiting until early teenage years may be more appropriate, as 23% of children diagnosed at age 4 spontaneously normalize their IgA levels by adolescence 2
- IgA levels between 7 mg/dL and the lower limit of normal should NOT be labeled as IgA deficiency 1
- Most IgA-deficient individuals (the majority) are completely asymptomatic 1, 3
Why You Cannot "Increase" IgA Levels
The fundamental problem is a B-cell maturation defect that prevents IgA production—this is a genetic/developmental issue, not a nutritional or reversible deficiency 3, 4. Unlike iron or vitamin deficiencies, you cannot supplement or stimulate IgA production.
Critical Management Principle:
No definitive therapy for selective IgA deficiency (SIGAD) exists 1. The guidelines are explicit: treatment targets complications, not the IgA level itself.
Management Algorithm for IgA Deficiency
Step 1: Identify and Remove Reversible Causes
First, investigate medication use—some drugs can cause acquired IgA deficiency that reverses upon discontinuation 1:
- Antiepileptics: phenytoin, carbamazepine, valproic acid, zonisamide
- Disease-modifying drugs: sulfasalazine, gold, penicillamine, hydroxychloroquine
- NSAIDs
If medication-induced, stop the offending drug and recheck levels after cessation.
Step 2: Treat Infections Aggressively
For patients with recurrent sinopulmonary infections, use aggressive antimicrobial therapy and consider prophylactic antibiotics 1. This is the primary intervention for symptomatic patients.
- Longer courses of antibiotics than standard protocols
- Consider long-term prophylaxis for frequent infections
- Early, aggressive treatment of acute infections
Step 3: Manage Associated Conditions
Treat atopic disease aggressively, as allergic inflammation predisposes to respiratory infections (sinusitis, otitis media) 1. This is particularly important because atopy occurs frequently with IgA deficiency.
Step 4: Consider IgG Replacement (Rare Cases Only)
Only rare patients with SIGAD might benefit from IVIG therapy—the majority will have minimal to no clinical response 1. Consider a trial only when:
- Recurrent infections severely impact quality of life
- Aggressive antibiotic therapy and prophylaxis have failed
- Patient has intolerable side effects or hypersensitivity to antibiotics
- Impaired antibody production is documented
Important Caveats:
Anti-IgA antibodies warning: Some IgA-deficient patients develop antibodies against IgA, creating a theoretical risk of anaphylaxis with blood products or IVIG 1. However, the actual risk to any individual patient is very small. Some patients who react to IVIG can tolerate subcutaneous IgG 1.
Monitor for progression: Some patients with SIGAD later develop common variable immunodeficiency (CVID)—these conditions exist on a spectrum 1, 5. Long-term vigilance is required for complications including respiratory/GI infections, autoimmune diseases, celiac disease, and malignancy 1.
What Does NOT Work
- No supplements, vitamins, or dietary interventions increase IgA
- No immunostimulants or immune boosters raise IgA levels
- IgA replacement therapy does not exist (unlike IgG replacement for other immunodeficiencies)
- Attempting to "boost immunity" with unproven therapies wastes time and money
Bottom Line
The question itself reflects a common misconception. You manage the patient, not the lab value. If asymptomatic (most cases), no intervention is needed beyond monitoring. If symptomatic, treat infections aggressively with antibiotics, manage allergies, and in rare refractory cases consider IVIG—but none of these raise IgA levels, they simply compensate for the deficiency's consequences 1, 3.